Europe diagnostics market is expected to grow at an impressive rate during the forecast period, 2024-2028. Growing incidences of various diseases along with extensive technological advancements in the country is likely to propel the growth of the market. Clinical diagnostics has open up new possibilities for early prevention and intervention by identifying the risk factors and early warning indications in a patient. As a result, it is projected that the entire market would continue to grow as the occurrences of chronic illnesses rises. Also, there is an increase in In-vitro diagnostic tests as well as increasing demand for genetic testing, which, in turn is surging the growth of the market.
Additionally, growing demand for Point-of-Care testing is a major factor for the market’s growth. This can be attributed to surging demand for self-testing diagnostics, and also the patient awareness regarding early diagnosis of the diseases. The growing popularity of personalized medicine among people for the treatments of several chronic diseases is likely to create lucrative opportunities for market growth over the next few years.
Growing Prevalence of Several Diseases and Disorders
According to the Global Cancer Observatory report, in 2020, 4,398,443 European people were suffering from cancer, out of which 1,955,231 people lost their lives due to cancer.
Increasing Aging Population
For instance
Recent Developments
- In 2021, Rocheintroduced its Cobas Pulse System in select countries accepting CE markapproval in Europe. The item is a networked point-of-care solution from RocheDiagnostics' latest generation. The most recent release offers expert bloodglucose management.
- In 2021, Hologic announcedthe European launch of Geniusâ„¢ Digital Diagnostics System for cervical cancerscreening. It is the next generation of cervical cancer screening that mergedeep learning-based artificial intelligence (AI) with advanced volumetricimaging technology to assist in identifying pre-cancerous lesions and cervicalcancer cells in women. It was developed to offer actionable insights, and to improveworkflow and lab efficiency, which primarily focus on eradicating cervicalcancer.
Download Free Sample Report
Market Segmentation
Europe diagnostics market is segmented into product, technology, application, end user, company and region. Based on product, the market is categorized into instruments, reagents, and software & services. Based on technology, the market is divided into
Market Players
Roche Diagnostics
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · Product · Technology · Application · End User · Country |
Country scope | France, Germany, United Kingdom, Italy, Spain, Finland, Greece, Portugal, Bulgaria, and Croatia. |
Key companies profiled | Roche Diagnostics GmbH, Ortho Clinical Diagnostics., Abbott Laboratories, Inc., Hologic, Inc. (Gen-Probe), Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation, Becton, Dickinson (BD) Company, Inc., bioMerieux, Inc., Siemens Healthcare GmbH. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |